Lataa...
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
Ameet Sarpatwari and Aaron Kesselheim explore whether stripping branded drugs of trademark protection would improve the efficiency and fairness of health care.
Tallennettuna:
| Julkaisussa: | PLoS Med |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4747525/ https://ncbi.nlm.nih.gov/pubmed/26859662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1001955 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|